pyrimethamine has been researched along with Leishmaniasis, Mucocutaneous in 3 studies
Maloprim: contains above 2 cpds
Leishmaniasis, Mucocutaneous: A disease characterized by the chronic, progressive spread of lesions from New World cutaneous leishmaniasis caused by species of the L. braziliensis complex to the nasal, pharyngeal, and buccal mucosa some time after the appearance of the initial cutaneous lesion. Nasal obstruction and epistaxis are frequent presenting symptoms.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 3 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
NEAL, RA | 1 |
Müller, E | 1 |
Sturm, G | 1 |
Halter, K | 1 |
Ruckes, J | 1 |
3 other studies available for pyrimethamine and Leishmaniasis, Mucocutaneous
Article | Year |
---|---|
CHEMOTHERAPY OF CUTANEOUS LEISHMANIASIS: LEISHMANIA TROPICA INFECTIONS IN MICE.
Topics: Amidines; Animals; Antimony; Antiprotozoal Agents; Chloroquine; Chlortetracycline; Dapsone; Deoxyrib | 1964 |
[Protozoan infections of the skin].
Topics: Amphotericin B; Antimony; Female; Germany, West; Humans; Leishmania; Leishmaniasis, Mucocutaneous; M | 1974 |
[Observation of a South American skin leishmaniasis in Germany].
Topics: Adult; Antiprotozoal Agents; Berlin; Chloroquine; Humans; Leishmaniasis, Mucocutaneous; Male; Pyrime | 1967 |